New drug combo aims to boost stroke recovery
NCT ID NCT07483281
First seen Mar 25, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether adding a drug called human urinary kallidinogenase to the standard clot-busting medicine reteplase helps people recover better after an acute ischemic stroke. About 220 adults who can be treated within 4.5 hours of stroke onset will be enrolled. The main goal is to see if more patients achieve a good functional outcome (no or minimal disability) at 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Union Hospital of Jilin University
Changchun, Jilin, 130033, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.